Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities

被引:3
|
作者
Walker, Meghan J. [1 ,2 ]
Blackmore, Kristina M. [1 ]
Chang, Amy [1 ]
Lambert-Cote, Laurence [3 ]
Turgeon, Annie [3 ]
Antoniou, Antonis C. [4 ]
Bell, Kathleen A. [1 ]
Broeders, Mireille J. M. [5 ]
Brooks, Jennifer D. [2 ]
Carver, Tim [4 ]
Chiquette, Jocelyne [3 ,6 ]
Despres, Philippe [7 ]
Easton, Douglas F. [4 ]
Eisen, Andrea [1 ,8 ]
Eloy, Laurence [9 ]
Evans, D. Gareth [10 ]
Fienberg, Samantha [1 ]
Joly, Yann [11 ]
Kim, Raymond H. [1 ,12 ]
Kim, Shana J. [2 ]
Knoppers, Bartha M. [11 ]
Lofters, Aisha K. [2 ,13 ]
Nabi, Hermann [3 ,14 ,15 ]
Paquette, Jean-Sebastien [6 ]
Pashayan, Nora [4 ,16 ]
Sheppard, Amanda J. [1 ,2 ]
Stockley, Tracy L. [17 ,18 ]
Dorval, Michel [3 ,15 ,19 ]
Simard, Jacques [3 ,20 ]
Chiarelli, Anna M. [1 ,2 ]
机构
[1] Ontario Hlth Canc Care Ontario, Toronto, ON M5G 2L3, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada
[3] Univ Laval, CHU Quebec, Res Ctr, Queebec City, PQ G1V 4G2, Canada
[4] Univ Cambridge, Ctr Canc Genet Epidemiol, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England
[5] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525EP Nijmegen, Netherlands
[6] Univ Laval, Fac Med, Dept Family Med & Emergency Med, Quebec City, PQ G1V 0A6, Canada
[7] Univ Laval, Fac Sci & Engn, Dept Phys Engn Phys & Opt, Quebec City, PQ G1V 0A6, Canada
[8] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[9] Minist Sante & Serv Sociaux, Quebec Canc Program, Quebec City, PQ G1S 2M1, Canada
[10] Univ Manchester, Div Evolut Infect & Genom Sci, Manchester M13 9PL, England
[11] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 0G1, Canada
[12] Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada
[13] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada
[14] Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ G1V 0A6, Canada
[15] Univ Laval, Canc Res Ctr, Quebec City, PQ G1R 3S3, Canada
[16] UCL, Inst Epidemiol & Healthcare, Dept Appl Hlth Res, London WC1E 6BT, England
[17] Univ Hlth Network, Div Clin Lab Genet, Toronto, ON M5G 2C4, Canada
[18] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
[19] Univ Laval, Fac Pharm, Quebec City, PQ G1V 0A6, Canada
[20] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada
关键词
breast cancer; breast cancer screening; risk assessment; polygenic risk score; risk stratification; implementation; HEALTH LITERACY; WOMEN;
D O I
10.3390/cancers16112116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Risk-stratified breast screening has been proposed as a strategy to overcome the limitations of age-based screening. A prospective cohort study was undertaken within the PERSPECTIVE I&I project, which will generate the first Canadian evidence on multifactorial breast cancer risk assessment in the population setting to inform the implementation of risk-stratified screening. Recruited females aged 40-69 unaffected by breast cancer, with a previous mammogram, underwent multifactorial breast cancer risk assessment. The adoption of multifactorial risk assessment, the effectiveness of methods for collecting risk factor information and the costs of risk assessment were examined. Associations between participant characteristics and study sites, as well as data collection methods, were assessed using logistic regression; all p-values are two-sided. Of the 4246 participants recruited, 88.4% completed a risk assessment, with 79.8%, 15.7% and 4.4% estimated at average, higher than average and high risk, respectively. The total per-participant cost for risk assessment was CAD 315. Participants who chose to provide risk factor information on paper/telephone (27.2%) vs. online were more likely to be older (p = 0.021), not born in Canada (p = 0.043), visible minorities (p = 0.01) and have a lower attained education (p < 0.0001) and perceived fair/poor health (p < 0.001). The 34.4% of participants requiring risk factor verification for missing/unusual values were more likely to be visible minorities (p = 0.009) and have a lower attained education (p <= 0.006). This study demonstrates the feasibility of risk assessment for risk-stratified screening at the population level. Implementation should incorporate an equity lens to ensure cancer-screening disparities are not widened.
引用
收藏
页数:25
相关论文
共 50 条
  • [41] The role of polygenic risk scores in breast cancer risk perception and decision-making
    Leslie Riddle
    Galen Joseph
    Mikaella Caruncho
    Barbara Ann Koenig
    Jennifer Elyse James
    Journal of Community Genetics, 2023, 14 : 489 - 501
  • [42] Utility of polygenic risk scores in UK cancer screening: a modelling analysis
    Huntley, Catherine
    Torr, Bethany
    Sud, Amit
    Rowlands, Charlie F.
    Way, Rosalind
    Snape, Katie
    Hanson, Helen
    Swanton, Charles
    Broggio, John
    Lucassen, Anneke
    McCartney, Margaret
    Houlston, Richard S.
    Hingorani, Aroon D.
    Jones, Michael E.
    Turnbull, Clare
    LANCET ONCOLOGY, 2023, 24 (06): : 658 - 668
  • [43] Polygenic risk scores and prostate cancer screening: a recipe for more overdiagnosis?
    Klein, Robert J.
    BJU INTERNATIONAL, 2022, 129 (03) : 271 - 271
  • [44] Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer
    McCarthy, Anne Marie
    Manning, Alisa K.
    Hsu, Sarah
    Welch, Michaela
    Moy, Beverly
    Lehman, Constance D.
    Armstrong, Katrina
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (02) : 389 - 398
  • [45] The role of polygenic risk scores in breast cancer risk perception and decision-making
    Riddle, Leslie
    Joseph, Galen
    Caruncho, Mikaella
    Koenig, Barbara Ann
    James, Jennifer Elyse
    JOURNAL OF COMMUNITY GENETICS, 2023, 14 (05) : 489 - 501
  • [46] Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
    Mavaddat, Nasim
    Ficorella, Lorenzo
    Carver, Tim
    Lee, Andrew
    Cunningham, Alex P.
    Lush, Michael
    Dennis, Joe
    Tischkowitz, Marc
    Downes, Kate
    Hu, Donglei
    Hahnen, Eric
    Schmutzler, Rita K.
    Stockley, Tracy L.
    Downs, Gregory S.
    Zhang, Tong
    Chiarelli, Anna M.
    Bojesen, Stig E.
    Liu, Cong
    Chung, Wendy K.
    Pardo, Monica
    Feliubadalo, Lidia
    Balmana, Judith
    Simard, Jacques
    Antoniou, Antonis C.
    Easton, Douglas F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (03) : 422 - 427
  • [47] Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer
    Anne Marie McCarthy
    Alisa K. Manning
    Sarah Hsu
    Michaela Welch
    Beverly Moy
    Constance D. Lehman
    Katrina Armstrong
    Breast Cancer Research and Treatment, 2022, 196 : 389 - 398
  • [48] Risk Assessment in Population-Based Breast Cancer Screening
    Eriksson, Mikael
    Conant, Emily F.
    Kontos, Despina
    Hall, Per
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (20) : 2279 - +
  • [49] Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2023, 44 (03) : 167 - 170
  • [50] Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry
    Du, Zhaohui
    Gao, Guimin
    Adedokun, Babatunde
    Ahearn, Thomas
    Lunetta, Kathryn L.
    Zirpoli, Gary
    Troester, Melissa A.
    Ruiz-Narvaez, Edward A.
    Haddad, Stephen A.
    PalChoudhury, Parichoy
    Figueroa, Jonine
    John, Esther M.
    Bernstein, Leslie
    Zheng, Wei
    Hu, Jennifer J.
    Ziegler, Regina G.
    Nyante, Sarah
    Bandera, Elisa, V
    Ingles, Sue A.
    Mancuso, Nicholas
    Press, Michael F.
    Deming, Sandra L.
    Rodriguez-Gil, Jorge L.
    Yao, Song
    Ogundiran, Temidayo O.
    Ojengbe, Oladosu
    Bolla, Manjeet K.
    Dennis, Joe
    Dunning, Alison M.
    Easton, Douglas F.
    Michailidou, Kyriaki
    Pharoah, Paul D. P.
    Sandler, Dale P.
    Taylor, Jack A.
    Wang, Qin
    Weinberg, Clarice R.
    Kitahara, Cari M.
    Blot, William
    Nathanson, Katherine L.
    Hennis, Anselm
    Nemesure, Barbara
    Ambs, Stefan
    Sucheston-Campbell, Lara E.
    Bensen, Jeannette T.
    Chanock, Stephen J.
    Olshan, Andrew F.
    Ambrosone, Christine B.
    Olopade, Olufunmilayo, I
    Yarney, Joel
    Awuah, Baffour
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (09): : 1168 - 1176